These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Immune profile of patients with reticuloplasmocytoma treated with alkeran and prednisone.
    Author: Urasiński I, Sochacka-Kuzko B, Fiedorowicz-Fabrycy I, Wichert K.
    Journal: Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):867-71. PubMed ID: 749835.
    Abstract:
    The humoral and cellular immune response was examined in 26 patients with reticuloplasmocytoma. In 14 patients the tests were repeated after 6-8 month treatment with Alkeran and Prednisone. The following parameters were determined: level of immunoglobulin G, A and M, lymphocyte count and differential count (T, B and O), leukocytes migration tests and tuberculine skin test. It appeared from our studies, that patients with reticuloplasmocytoma have defects in humoral and cellular responses, however, the treatment applied, did not influence any of the measured parameters.
    [Abstract] [Full Text] [Related] [New Search]